Literature DB >> 19131901

Trends in otitis media and myringtomy with tube placement among American Indian/Alaska native children and the US general population of children.

Rosalyn J Singleton1, Robert C Holman, Randall Plant, Krista L Yorita, Steve Holve, Edna L Paisano, James E Cheek.   

Abstract

BACKGROUND: Otitis media (OM) morbidity in American Indian and Alaska Native (AI/AN) children is historically higher than that in other US children.
METHODS: Outpatient visits and hospitalizations listing OM as a diagnosis and outpatient visits listing myringotomy with insertion of tubes as a procedure among AI/AN children <5 years of age from the Indian Health Service National Patient Information Reporting system for 2003-2005 were analyzed. Outpatient visits and hospitalizations with OM for the general US child population were analyzed using the National Hospital Ambulatory Medical Care and National Ambulatory Medical Care Surveys for 2003-2005, and the 2003 Kids' Inpatient Database, respectively.
RESULTS: The OM-associated outpatient visit rate for AI/AN children <5 years of age (89 per 100 children/yr) for 2003-2005 was less than that reported for 1994-1996 (138); however, the rate increased for Alaska region (158 to 181). The OM outpatient visit and myringotomy with insertion of tubes rates (181 and 2.6 per 100 children/yr, respectively) for AI/AN children in Alaska were higher than rates for children in each of the other IHS regions and rates for US children (63 and 1.8 per 100 children/yr, respectively). The OM outpatient visit rates for AI/AN infants (184), especially in the Alaska region (334), were higher than the rate for US infants (84).
CONCLUSIONS: The OM-associated outpatient visit rate in AI/AN children <5 years of age has decreased but remains higher than that of the US general child population; however, the rate increased in the Alaska region, where a limited decline in invasive pneumococcal disease has been demonstrated. The ongoing disparity in OM outpatient visit rates among AI/AN children, especially Alaska Native children, indicates a need for new prevention measures, including expanded-valency pneumococcal conjugate vaccines, to reduce OM morbidity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19131901     DOI: 10.1097/INF.0b013e318188d079

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  13 in total

1.  Disparities in infectious disease hospitalizations for American Indian/ Alaska Native people.

Authors:  Robert C Holman; Arianne M Folkema; Rosalyn J Singleton; John T Redd; Krista Y Christensen; Claudia A Steiner; Lawrence B Schonberger; Thomas W Hennessy; James E Cheek
Journal:  Public Health Rep       Date:  2011 Jul-Aug       Impact factor: 2.792

2.  Expanding Clinical Trials Designs to Extend Equitable Hearing Care.

Authors:  Rolvix Patterson; Marissa Schuh; Matthew L Bush; Carrie L Nieman; Samantha Kleindienst Robler; Susan D Emmett
Journal:  Ear Hear       Date:  2020-06-13       Impact factor: 3.562

3.  Clinical perspectives on nasopharyngeal morphology in humans.

Authors:  Rebecca Rohde; David R Friedland
Journal:  Anat Rec (Hoboken)       Date:  2022-04-06       Impact factor: 2.227

4.  Impact of pneumococcal conjugate vaccines on microbial epidemiology and clinical outcomes of acute otitis media.

Authors:  Isabelle Hau; Corinne Levy; Laurence Caeymaex; Robert Cohen
Journal:  Paediatr Drugs       Date:  2014-02       Impact factor: 3.022

5.  Assessment of the association between atopic conditions and tympanostomy tube placement in children.

Authors:  Kara A Bjur; Rachel L Lynch; Yilma A Fenta; Kwang Ha Yoo; Robert M Jacobson; Xujian Li; Young J Juhn
Journal:  Allergy Asthma Proc       Date:  2012 May-Jun       Impact factor: 2.587

Review 6.  Impact of pneumococcal conjugate vaccination on otitis media: a systematic review.

Authors:  Sylvia Taylor; Paola Marchisio; Anne Vergison; Julie Harriague; William P Hausdorff; Mark Haggard
Journal:  Clin Infect Dis       Date:  2012-03-15       Impact factor: 9.079

7.  Impact of pneumococcal conjugate vaccine on pediatric tympanostomy tube insertion in partial immunized population.

Authors:  Mao-Che Wang; Ying-Piao Wang; Chia-Huei Chu; Tzong-Yang Tu; An-Suey Shiao; Pesus Chou
Journal:  ScientificWorldJournal       Date:  2015-03-09

8.  Reduction in all-cause otitis media-related outpatient visits in children after PCV10 introduction in Brazil.

Authors:  Ana L Sartori; Ruth Minamisava; Ana L Bierrenbach; Cristiana M Toscano; Eliane T Afonso; Otaliba L Morais-Neto; José L F Antunes; Elier B Cristo; Ana Lucia Andrade
Journal:  PLoS One       Date:  2017-06-08       Impact factor: 3.240

9.  Pneumococcal conjugate vaccines and otitis media.

Authors:  Sylvia Taylor; Paola Marchisio; Anne Vergison; William P Hausdorff; Mark Haggard
Journal:  Int J Otolaryngol       Date:  2012-11-13

10.  Increasing trend in the rate of infectious disease hospitalisations among Alaska Native people.

Authors:  Robert C Holman; Thomas W Hennessy; Dana L Haberling; Laura S Callinan; Rosalyn J Singleton; John T Redd; Claudia A Steiner; Michael G Bruce
Journal:  Int J Circumpolar Health       Date:  2013-08-05       Impact factor: 1.228

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.